twoXAR is a pharmaceutical company with a broad portfolio of disease areas. By combining steps from the traditional multi-step approach that typically limits the pace of drug discovery, twoXAR is able to rapidly de-risk opportunities and progress drug candidates through industry and investor partnerships.

  • Our vision is to become the global leader in drug discovery and development by developing new medicines to benefit a billion patients.



    The convergence of big data, cloud computing, and artificial intelligence has allowed twoXAR to build a drug discovery platform that is orders of magnitude faster, cheaper, and more accurate than traditional approaches.


    twoXAR leverages its AI technology internally to build its own pipeline of therapeutic candidates across diseases as well as collaborate with biotechnology and pharmaceutical companies to jointly discover and develop novel drug candidates.​